STOCK TITAN

Zai Lab (ZLAB) files Form 144 to sell $493K in ADS on 6/20/25

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Zai Lab Limited (NASDAQ: ZLAB) has filed a Form 144 indicating a proposed insider sale.

  • Securities: 13,814 American Depositary Shares (ADS).
  • Aggregate market value: US$492,745.38.
  • % of shares outstanding: ~0.003% of the 486,853,250 ADS outstanding, a very small fraction.
  • Planned sale date: 20 June 2025.
  • Acquisition source: Restricted-stock vesting on 18 June 2025; consideration classified as compensation.
  • Broker: Fidelity Brokerage Services LLC, Smithfield, RI.

The filing is routine, signalling an intention—rather than an executed transaction—to dispose of recently vested shares. No prior sales were reported in the past three months, and the filer affirms lack of undisclosed material adverse information. Given the minuscule size relative to the public float, the notice is unlikely to have a material valuation impact but may interest investors tracking insider trading trends.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Minor Form 144 shows insider plans to sell 13.8k ADS (~$0.5 M), just 0.003% of float—neutral market impact.

The Form 144 discloses a prospective sale of 13,814 ZLAB ADS, valued at roughly US$493 k, with settlement targeted for 20 June 2025. The shares stem from a standard restricted-stock vest that occurred two days earlier. Given the immense share base of 486.9 million ADS, the stake represents a negligible slice of equity and does not meaningfully alter insider ownership levels. The absence of other recent sales and the Rule 144 certification that no undisclosed adverse information exists further diminishes any negative signalling. Overall, this is an administrative disclosure with no material capital-markets ramifications.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ZLAB shares are covered by the Form 144 notice?

The filing covers 13,814 American Depositary Shares.

What is the approximate dollar value of the proposed ZLAB insider sale?

The aggregate market value is US$492,745.38.

When is the planned sale date for the ZLAB ADS under Form 144?

The filer listed an approximate sale date of 20 June 2025.

What percentage of ZLAB’s outstanding shares does the 13,814 ADS represent?

The sale equals roughly 0.003% of the 486,853,250 ADS outstanding.

How were the shares originally acquired by the insider?

They were obtained via restricted-stock vesting on 18 June 2025, classified as compensation.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

1.99B
106.68M
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI